发明名称 |
USE OF MYELOID CELL BIOMARKERS FOR THE DIAGNOSIS OF CANCER |
摘要 |
The present invention relates to the use of myeloid cell biomarkers for the differential diagnosis, prognosis, and monitoring of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to monitoring the effect of a treatment against renal cell carcinoma (RCC) or colorectal cancer (CRC), and establishing a prognosis of the outcome of the treatment of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to panels of cellular biomarkers for use in the above methods, in particular multicolor panels for measuring said biomarkers. |
申请公布号 |
SG188543(A1) |
申请公布日期 |
2013.04.30 |
申请号 |
SG20130018973 |
申请日期 |
2011.09.21 |
申请人 |
IMMATICS BIOTECHNOLOGIES GMBH |
发明人 |
SINGH, HARPREET;WALTER, STEFFEN;MENDRZYK, REGINA;BRONTE, VINCENZO;MANDRUZZATO, SUSANNA |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|